Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?

Patients with antiphospholipid syndrome (APS) are at increased risk of recurrent thromboembolic events due to the pathology of the disease. While prolonged anticoagulation is the treatment of choice for patients with thrombosis, much debate remains about the optimum intensity of anticoagulation. Ant...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cureus
Main Authors: Kim, Esther, Do, Tiffanie, Peacock, Katie, Takundwa, Prisca T
Formato: Artigo
Idioma:Inglês
Publicado: Cureus 2016
Assuntos:
Rheumatology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045335/
https://ncbi.nlm.nih.gov/pubmed/27725921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.765
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares